Table 2. Descriptive characteristics of women with CD4 counts ≤200 cells/µL.
Model 1 (integrated) | Model 2 (proximal) | Model 3 (distal) | P-value* | Total | |||||
Women with CD4 cell counts ≤200 cells/µl | 252 | 36.1% | 277 | 39.7% | 169 | 24.2% | 0.037 | 698 | |
Median age at 1st presentation (SD) | 29 | (24–32) | 28 | (24–32) | 28 | (24–32) | 0.3708 | 28 | (24–32) |
Median gestational age in weeks at 1st presentation (557/698 women with available data, IQR) | 26 | (21–32) | 27 | (21–32) | 23 | (19–28) | <0.001 | 26 | (21–31) |
Nulliparous (522/698 women with available data) | 63 | 12.1% | 73 | 14.0% | 40 | 7.7% | 0.646 | 176 | |
Median CD4 cell count (cells/µl, IQR) | 144 | (106–172) | 139 | (103–167) | 145 | (99–175) | 0.2632 | 142 | (103–171) |
Initiated ART before antenatal presentation | 37 | 14.7% | 30 | 10.8% | 14 | 8.3% | 0.048 | 81 | 11.6% |
Eligible women who had not initiated ART before antenatal presentation | 215 | 85.3% | 247 | 89.2% | 155 | 91.7% | 617 | 88.4% | |
Initiated Antenatal ART (% of remaining eligible women who had not initiated beforeantenatal presentation) | 120 | 55.8% | 94 | 38.1% | 70 | 45.2% | 0.003 | 284 | 46.0% |
Did not initiate antenatal ART (% of remaining women who had not initiated before antenatal presentation) | 77 | 35.8% | 115 | 46.6% | 64 | 41.3% | 256 | 41.5% | |
Unknown (Eligible by CD4 test result, patient folder missing) | 18 | 8.4% | 38 | 15.4% | 21 | 13.5% | 77 | 12.5% | |
No documentation of antenatal ART (% of remaining eligible women who were notdocumented as being on ART by delivery) | 95 | 44.2% | 153 | 61.9% | 85 | 54.8% | 333 | 54.0% | |
Received single or dual prophylaxis (% of women who did not receive ART antenatally orwhose intervention status was unknown) | 40 | 18.6% | 58 | 23.5% | 51 | 32.9% | 0.015 | 149 | 24.1% |
Initiated ART postpartum | 46 | 21.4% | 50 | 20.2% | 29 | 18.7% | 0.228 | 125 | 20.3% |
ART coverage at delivery (% of all women who were on ART at delivery) | 157 | 62.3% | 124 | 44.8% | 84 | 49.7% | 0.001 | 365 | 52.3% |
Median gestational age in weeks at 1st presentation (500/617 women with available data, IQR) | 26 | (21–31) | 27 | (21–32) | 23 | (19–29) | <0.001 | 26 | (21–31) |
Median gestational age at ART initiation (of 164/284 women with available data, IQR) | 31 | (28–34) | 31 | (28–34) | 30 | (27–34) | 0.946 | 31 | (28–34) |
Bivariable associations derived using Kruskall-Wallis and Pearson Chi 2 tests